J.P. Morgan analyst Lisa Gill maintained a Buy rating on Option Care Health (NASDAQ:OPCH) on Friday, setting a price target of $31, which is approximately 16.94% above the present share price of $26.51.
Gill expects Option Care Health to post earnings per share (EPS) of $0.20 for the fourth quarter of 2021.
The current consensus among 7 TipRanks analysts is for a Strong Buy rating of shares in Option Care Health, with an average price target of $31.29.
The analysts price targets range from a high of $35 to a low of $30.
In its latest earnings report, released on 09/30/2021, the company reported a quarterly revenue of $891.94 million and a net profit of $52.88 million. The company's market cap is $4.77 billion.
According to TipRanks.com, J.P. Morgan analyst Lisa Gill is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 18.4% and a 63.16% success rate.
Option Care Health, Inc. provides home and alternate site infusion services. The company was founded in 1996 and is headquartered in Bannockburn, IL.